Latest Commercialization News

Estrella Resources has reported exceptional manganese assay results from its Lautém Project in Timor-Leste, revealing grades up to 58.6% Mn and paving the way for imminent drilling activities.

New Zealand Coastal Seafoods reports a sharp reduction in losses following the closure of its New Zealand operations and reveals promising initial fishing results in the Coral Sea. The company is actively exploring commercial opportunities for its Coral Sea Fishery permits and a potential acquisition to boost future revenues.

Island Pharmaceuticals has successfully completed patient dosing in the Phase 2b therapeutic arm of its PROTECT clinical trial for ISLA-101, targeting dengue fever treatment. High-level results are expected within two months, potentially advancing a significant antiviral candidate.

NoviqTech partners with H2i Group to tokenise emissions reductions from hydrogen-enhanced diesel engines, aiming to revolutionise carbon credit markets with real-time blockchain tracking.

Bridge SaaS Limited has appointed Richard Gordon as CEO, signaling a strategic push to expand its footprint in the NDIS sector through acquisitions and technology innovation.

MTM Critical Metals has announced a breakthrough in recovering gallium and germanium from semiconductor waste using its proprietary Flash Joule Heating technology, achieving recovery rates that rival traditional methods while offering a more sustainable and scalable solution.

Qualitas Real Estate Income Fund (ASX: QRI) has launched a $151 million non-renounceable entitlement offer to existing unitholders, aiming to boost portfolio diversification and liquidity by investing in commercial real estate loans.

Vection Technologies has secured a three-year, AUD$575k partnership with global insurer Generali to deploy AI-driven extended reality solutions enhancing workplace safety and client engagement.

EMVision Medical Devices has secured US ethics approval for its pivotal multi-centre trial of the EMVision emu™ brain scanner, paving the way for a March 2025 trial start aimed at FDA clearance.

Suncorp Group Limited reported a robust half-year result for 1H25, with net profit after tax nearly doubling to $1.1 billion, driven by the sale of Suncorp Bank and strong insurance operations. The company announced a substantial capital return and special dividend, underscoring its disciplined capital management.

Genesis Energy and New Zealand’s top generators are exploring extending Huntly Power Station’s life to address supply risks highlighted by winter 2024’s energy crunch.

The Commonwealth Bank of Australia has released its December 2024 Basel III Pillar 3 report, reaffirming strong capital adequacy and liquidity positions despite evolving regulatory frameworks.